Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Covington
Chinese Patent Office
QuintilesIMS
Cerilliant
AstraZeneca
Baxter
Fuji
Citi
Johnson and Johnson

Generated: February 20, 2018

DrugPatentWatch Database Preview

Uridine triacetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for uridine triacetate and what is the scope of uridine triacetate freedom to operate?

Uridine triacetate
is the generic ingredient in two branded drugs marketed by Wellstat Therap and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Uridine triacetate has one hundred and seventy-five patent family members in twenty-one countries.

There are thirty-five drug master file entries for uridine triacetate. One supplier is listed for this compound.
Summary for uridine triacetate
Pharmacology for uridine triacetate

US Patents and Regulatory Information for uridine triacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Wellstat Therap VISTOGARD uridine triacetate GRANULE;ORAL 208159-001 Dec 11, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wellstat Therap VISTOGARD uridine triacetate GRANULE;ORAL 208159-001 Dec 11, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Wellstat Therap VISTOGARD uridine triacetate GRANULE;ORAL 208159-001 Dec 11, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wellstat Therap VISTOGARD uridine triacetate GRANULE;ORAL 208159-001 Dec 11, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wellstat Therap VISTOGARD uridine triacetate GRANULE;ORAL 208159-001 Dec 11, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wellstat Therap XURIDEN uridine triacetate GRANULE;ORAL 208169-001 Sep 4, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for uridine triacetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,173,017 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis ➤ Try a Free Trial
6,274,563 Acylated uridine and cytidine and uses thereof ➤ Try a Free Trial
6,329,350 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis ➤ Try a Free Trial
5,246,708 Methods for promoting wound healing with deoxyribonucleosides ➤ Try a Free Trial
5,691,320 Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis ➤ Try a Free Trial
6,020,322 Acyl deoxyribonucleoside derivatives and uses thereof ➤ Try a Free Trial
6,919,320 Pharmaceutical compositions containing deoxyribonucleosides for wound healing ➤ Try a Free Trial
6,344,447 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides ➤ Try a Free Trial
6,232,298 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis ➤ Try a Free Trial
5,736,531 Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for uridine triacetate

Supplementary Protection Certificates for uridine triacetate

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00036 Denmark ➤ Try a Free Trial PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF TIPIRACIL; REG. NO/DATE: EU/1/16/1096 20160427
0889 Netherlands ➤ Try a Free Trial PRODUCT NAME: TRIFLURIDINE IN COMBINATIE MET TIPIRACIL OF EEN ZOUT VAN TIPIRACIL, ZOALS TIPIRACILHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160427
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Merck
Cipla
Federal Trade Commission
Chinese Patent Office
Fish and Richardson
Colorcon
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot